These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27032393)

  • 1. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.
    Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL
    J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
    Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
    BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
    Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N
    PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves
    Gingold-Belfer R; Kessler-Icekson G; Morgenstern S; Rath-Wolfson L; Zemel R; Boltin D; Levi Z; Herman-Edelstein M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
    Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
    Front Immunol; 2022; 13():922138. PubMed ID: 36090985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample.
    Sipponen P; Kekki M; Siurala M
    Cancer; 1983 Sep; 52(6):1062-8. PubMed ID: 6883274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia.
    Ding L; Hayes MM; Photenhauer A; Eaton KA; Li Q; Ocadiz-Ruiz R; Merchant JL
    J Clin Invest; 2016 Aug; 126(8):2867-80. PubMed ID: 27427984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer.
    Liu LM; Yan MG; Yang DH; Sun WW; Zhang JX
    Eur J Intern Med; 2011 Oct; 22(5):e31-5. PubMed ID: 21925039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk.
    Bilgiç F; Gerçeker E; Boyacıoğlu SÖ; Kasap E; Demirci U; Yıldırım H; Baykan AR; Yüceyar H
    Turk J Gastroenterol; 2018 Jul; 29(4):427-435. PubMed ID: 30249557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
    Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
    Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
    Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
    Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TERT in precancerous gastric lesions compared to gastric cancer.
    Duarte MC; Babeto E; Leite KR; Miyazaki K; Borim AA; Rahal P; Silva AE
    Braz J Med Biol Res; 2011 Feb; 44(2):100-4. PubMed ID: 21180888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
    Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
    Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.
    Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A
    BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer.
    Dilaghi E; Baldaro F; Pilozzi E; Conti L; Palumbo A; Esposito G; Annibale B; Lahner E
    Am J Gastroenterol; 2021 Sep; 116(9):1859-1867. PubMed ID: 34313623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
    Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
    Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.
    Krishnan V; Lim DXE; Hoang PM; Srivastava S; Matsuo J; Huang KK; Zhu F; Ho KY; So JBY; Khor C; Tsao S; Teh M; Fock KM; Ang TL; Jeyasekharan AD; Tan P; Yeoh KG; Ito Y
    Gut; 2020 Oct; 69(10):1738-1749. PubMed ID: 31937549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.